Cellectar Biosciences Statistics

Total Valuation

CLRB has a market cap or net worth of $13.41 million. The enterprise value is -$21.41 million.

Market Cap	13.41M
Enterprise Value	-21.41M

Important Dates

The last earnings date was Monday, November 18, 2024, before market open.

Earnings Date	Nov 18, 2024
Ex-Dividend Date	n/a

Share Statistics

CLRB has 41.27 million shares outstanding. The number of shares has increased by 173.55% in one year.

Current Share Class	41.27M
Shares Outstanding	41.27M
Shares Change (YoY)	+173.55%
Shares Change (QoQ)	+6.27%
Owned by Insiders (%)	2.88%
Owned by Institutions (%)	21.69%
Float	34.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.83
P/TBV Ratio	7.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.03.

Current Ratio	1.77
Quick Ratio	1.69
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -474.63% and return on invested capital (ROIC) is -290.49%.

Return on Equity (ROE)	-474.63%
Return on Assets (ROA)	-109.57%
Return on Capital (ROIC)	-290.49%
Revenue Per Employee	n/a
Profits Per Employee	-$2.51M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-60,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.40% in the last 52 weeks. The beta is 0.87, so CLRB's price volatility has been lower than the market average.

Beta (5Y)	0.87
52-Week Price Change	-88.40%
50-Day Moving Average	1.35
200-Day Moving Average	2.36
Relative Strength Index (RSI)	18.66
Average Volume (20 Days)	4,878,475

Short Selling Information

The latest short interest is 2.79 million, so 6.77% of the outstanding shares have been sold short.

Short Interest	2.79M
Short Previous Month	1.30M
Short % of Shares Out	6.77%
Short % of Float	8.18%
Short Ratio (days to cover)	8.34

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-51.58M
Pretax Income	-51.04M
Net Income	-50.11M
EBITDA	-51.29M
EBIT	-51.58M
Earnings Per Share (EPS)	-$1.92

Full Income Statement

Balance Sheet

The company has $34.26 million in cash and $512,750 in debt, giving a net cash position of $33.75 million or $0.82 per share.

Cash & Cash Equivalents	34.26M
Total Debt	512,750
Net Cash	33.75M
Net Cash Per Share	$0.82
Equity (Book Value)	16.55M
Book Value Per Share	0.04
Working Capital	15.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$46.27 million and capital expenditures -$309,665, giving a free cash flow of -$46.57 million.

Operating Cash Flow	-46.27M
Capital Expenditures	-309,665
Free Cash Flow	-46.57M
FCF Per Share	-$1.13

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLRB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-173.55%
Shareholder Yield	-173.55%
Earnings Yield	-406.07%
FCF Yield	-377.44%

Analyst Forecast

The average price target for CLRB is $28.00, which is 8,518.04% higher than the current price. The consensus rating is "Buy".

Price Target	$28.00
Price Target Difference	8,518.04%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 22, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jul 22, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2